contents area
Press Release
detail content area
- Date2020-09-15 18:20
- Update2020-09-15 18:20
- Division국제협력담당관(Director for International Affairs)
- Tel043-719-7753
- 247
□ As of 0:00, 15 September 2020, the total number of confirmed cases is 22,391 (including 3,029 imported cases), of which 18,878 cases have been discharged from isolation. There are 91 new local cases, 15 new imported cases, and 4 new deaths.
|
Local transmission cases, as of 0:00, 15 September (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Imported cases, as of 0:00, 15 September (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
※ Asia excluding China: Russia 2, Philippines 1, Indonesisa 1, Kuwait 1 / Europe: Poland 1, Turkey 1 America: US 6, Mexico 2 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Case status, as of 0:00, 15 September (cumulative since 3 January 2020) |
||||||||||||||||||||
|
||||||||||||||||||||
|
* Based on case data reported to the KDCA ** Critical: patients treated with mechanical ventilator, ECMO Extracorporeal Membrane Oxygenation), CRRT(Continuous Renal Replacement Therapy) / Severe: patients treated with oxygen mask and high flow of oxygen therapy ※ Figures subject to correction based on findings from epidemiological investigations |
||||||||||||||||||||
|
|
|
Overall case and test status, as of 0:00, 15 September (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
* Based on case data reported to the KDCA ** Testing in progress includes number of completed tests with negative results that are being recorded with delays ※ Figures subject to correction based on findings from epidemiological investigations
|
||||||||||||||||||||||||||||||||||||||||||||
|
Regional distribution of cases, as of 0:00, 15 September (cumulative since 3 January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Total (cumulative) number of cases reported since January 2020 of region / Population of region (based on resident registration data of the Ministry of the Interior as of January 2020) * Incidence rate based on the number of confirmed cases with the address of the reporting institution |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Major local clusters as of 12:00 today (15 September 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
* The specific figures may differ from the daily reported statistics or figures disclosed by local municipalities due to factors such as report timing and differences in the time period considered |
□ 2,642 eligible people have signed up to donate their plasma for the development of COVID-19 plasma therapy. Plasma collection has been completed for 1,957 people. KDCA thanks all volunteers and encourages more people to participate.
□ Convalescent plasma has been given to 39 COVID-19 patients in 7 hospitals.
□ Remdesivir has been supplied to 370 COVID-19 patients in 53 hospitals.
□ Social Distancing Level 2 is in effect for the greater capital area until 27 September. KDCA requests the public to continue to follow the guidelines for COVID-19 prevention.
|
REGIONAL DISTRIBUTION AND EPIDEMIOLOGICAL LINKS OF CONFIRMED CASES |
||||||||||
|
|
||||||||||
|
Region |
Confirmed cases |
Other major clusters |
||||||||
|
Total |
Imported cases |
Clusters |
Other* |
Under investigation |
New cases |
|||||
|
Sub- total |
Shin- cheonji cluster |
Other local clusters |
Related to imported cases |
|||||||
|
Seoul |
4,743 |
400 |
2,640 |
8 |
2,561 |
71 |
814 |
889 |
32 |
Past large clusters: • Sarang Jeil Church (1168) • Aug 15 Seoul rallies (582) • Nightclubs (277) • Richway (208) • Guro-gu call center (170) • Coupang fulfillment center (152) • Gwangju door-to-door sales (150) • Fitness/sport facility in Cheonan (123) • Newly planted churches group (119) Recent clusters: • Anyang snack bar • K Health Industries • Ginseng business seminar • Kimchi factory in Cheongyang-gun • Incheon Seo-gu Office • Anyang/Gunpo social gathering • TR Innovation / Sara Queen • Severance Hospital • Nichiren Shoshu Seoul Mission • Coupang Songpa 2 Camp • Jongno-gu Office worker • Guro-gu apartments / Geumcheon-gu livestock business • Indoor fitness facility in Wonju • Online hiking group • Suncheonhyang University Cheonan Hospital |
|
Busan |
361 |
46 |
220 |
12 |
153 |
55 |
46 |
49 |
4 |
|
|
Daegu |
7,112 |
79 |
5,361 |
4,512 |
845 |
4 |
927 |
745 |
0 |
|
|
Incheon |
843 |
93 |
565 |
2 |
555 |
8 |
98 |
87 |
9 |
|
|
Gwangju |
482 |
50 |
344 |
9 |
329 |
6 |
57 |
31 |
1 |
|
|
Daejeon |
345 |
27 |
163 |
2 |
161 |
0 |
108 |
47 |
3 |
|
|
Ulsan |
141 |
36 |
64 |
16 |
44 |
4 |
28 |
13 |
0 |
|
|
Sejong |
70 |
9 |
47 |
1 |
45 |
1 |
10 |
4 |
0 |
|
|
Gyeonggi |
3,972 |
546 |
2,225 |
29 |
2,130 |
66 |
649 |
552 |
39 |
|
|
Gangwon |
217 |
26 |
132 |
17 |
114 |
1 |
35 |
24 |
1 |
|
|
Chung- buk |
149 |
29 |
68 |
6 |
55 |
7 |
27 |
25 |
2 |
|
|
Chung- nam |
445 |
52 |
247 |
0 |
246 |
1 |
83 |
63 |
3 |
|
|
Jeonbuk |
101 |
35 |
33 |
1 |
32 |
0 |
22 |
11 |
1 |
|
|
Jeonnam |
166 |
33 |
76 |
1 |
73 |
2 |
45 |
12 |
0 |
|
|
Gyeong- buk |
1,489 |
52 |
1,107 |
566 |
541 |
0 |
197 |
133 |
1 |
|
|
Gyeong- nam |
271 |
70 |
161 |
32 |
126 |
3 |
17 |
23 |
2 |
|
|
Jeju |
56 |
18 |
11 |
0 |
10 |
1 |
19 |
8 |
3 |
|
|
Ports of Entry |
1,428 |
1,428 |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
|
|
Total |
22,391 |
3,029 |
13,464 |
5,214 |
8,020 |
230 |
3,182 |
2,716 |
106 |
|
|
(%) |
(13.5) |
(60.1) |
(23.3) |
(35.8) |
(1.0) |
(14.2) |
(12.1) |
|||
|
* Includes contacts of confirmed cases ※ The interim classification is based on the reporting location, which may change depending on further epidemiological investigation. |
||||||||||
|
AGE DISTRIBUTION OF SEVERE CASES |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Total |
Severe |
( |
% |
) |
Critical |
( |
% |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Total |
158 |
85 |
( |
100 |
) |
73 |
( |
100 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
80 and above |
32 |
22 |
( |
25.9 |
) |
10 |
( |
13.7 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
70-79 |
61 |
23 |
( |
27.1 |
) |
38 |
( |
52.1 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
60-69 |
44 |
25 |
( |
29.4 |
) |
19 |
( |
26.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
50-59 |
14 |
10 |
( |
11.8 |
) |
4 |
( |
5.5 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
40-49 |
6 |
4 |
( |
4.7 |
) |
2 |
( |
2.7 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
30-39 |
1 |
1 |
( |
1.2 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
20-29 |
0 |
0 |
( |
0.0 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
10-19 |
0 |
0 |
( |
0.0 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
0-9 |
0 |
0 |
( |
0.0 |
) |
0 |
( |
0.0 |
) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Confirmed cases by gender and age group |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Total (cumulative) number of cases reported since January 2020 by sex and age / Population by sex and age (based on resident registration data of the Ministry of the Interior as of January 2020) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Deaths by gender and age group |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
IMPORTED CONFIRMED CASES |
 |
|
|
|
NEW CASES (LAST 2 WEEKS) BY CHAIN OF TRANSMISSION |
|
This public work may be used under the terms of the public interest source + commercial use prohibition + nonrepudiation conditions